Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.990
-0.010 (-0.33%)
Jan 30, 2025, 4:00 PM EST - Market closed
Akoya Biosciences Employees
Akoya Biosciences had 330 employees as of December 31, 2023. The number of employees decreased by 39 or -10.57% compared to the previous year.
Employees
330
Change (1Y)
-39
Growth (1Y)
-10.57%
Revenue / Employee
$263,076
Profits / Employee
-$175,661
Market Cap
148.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 330 | -39 | -10.57% |
| Dec 31, 2022 | 369 | 50 | 15.67% |
| Dec 31, 2021 | 319 | 150 | 88.76% |
| Dec 31, 2020 | 169 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
AKYA News
- 2 days ago - Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
- 20 days ago - AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - Business Wire
- 20 days ago - Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers - Business Wire
- 7 weeks ago - Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions - GlobeNewsWire
- 2 months ago - Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Akoya Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 - GlobeNewsWire
- 4 months ago - Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy - GlobeNewsWire